Recombinant CTLA-4 (Tremelimumab Biosimilar) antibody

Catalog No. ABIN7581356

This anti-CTLA-4 (Tremelimumab Biosimilar) antibody is a Human Monoclonal antibody detecting CTLA-4 (Tremelimumab Biosimilar) in FACS, BLI, ELISA, Func and SPR. Suitable for Human.

Quick Overview for Recombinant CTLA-4 (Tremelimumab Biosimilar) antibody (ABIN7581356)

Target: CTLA-4 (Tremelimumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CTLA-4 (Tremelimumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CTLA-4 (Tremelimumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CTLA-4 / CD152 Reference Antibody (tremelimumab)

Characteristics: Anti-CTLA-4 / CD152 Reference Antibody (tremelimumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CTLA-4 (Tremelimumab Biosimilar)

Target: CTLA-4 (Tremelimumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P16410